Dimethylformamide

Dimethylformamide

SCHEMBL9210995

CN(C)C=O.S

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103635491-B Class shark chondroitine and preparation method thereof GNOSIS S.P.A. (IT) 2016-05-11 CN claimed
EP-3166981-B1 OLIGOSACCHARIDE COMPOSITIONS AND METHODS FOR PRODUCING THEREOF DSM NUTRITIONAL PRODUCTS LLC (US) 2026-05-13 EP disclosed
EP-4079305-B1 COMPOUNDS FOR USE IN THE TREATMENT OF PNEUMONIA CAUSED BY CERTAIN CARBAPENEM-RESISTANT OR CARBAPENEM-SUSCEPTIBLE BACTERIA SHENZHEN OPTIMUM BIOLOGICAL TECH CO LTD (CN) 2026-02-18 EP disclosed
US-12514267-B2 Oligosaccharide compositions for use as animal feed and methods of producing thereof DSM NUTRITIONAL PRODUCTS, LLC (US) 2026-01-06 US disclosed
US-12491180-B2 Application of compound in treating pneumonia Shenzhen Optimum Biological Technology Co., Ltd (CN) 2025-12-09 US disclosed
EP-3901150-B1 MONOCYCLIC BETA-LACTAM COMPOUND FOR USE IN THE TREATMENT OF PNEUMONIA SHENZHEN OPTIMUM BIOLOGICAL TECH CO LTD (CN) 2025-12-03 EP disclosed
US-12310948-B2 Application of monocyclic β-lactam compound in pharmacy Shenzhen Optimum Biological Technology Co., Ltd (CN) 2025-05-27 US disclosed
WO-2025059069-A1 NLRP3 MODULATORS ZOMAGEN BIOSCIENCES LTD (US) 2025-03-20 WO disclosed
US-20250057202-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE AS FOOD INGREDIENTS AND METHODS OF PRODUCING THEREOF DSM NUTRITIONAL PRODUCTS LLC (US) 2025-02-20 US disclosed
US-20240327413-A1 NLRP3 MODULATORS ZOMAGEN BIOSCIENCES LTD 2024-10-03 US disclosed
CN-105859609-A Beta-lactamase inhibitor and process for preparing the same 明治制果药业株式会社 2016-08-17 CN disclosed
CN-103635491-B Class shark chondroitine and preparation method thereof GNOSIS S.P.A. (IT) 2016-05-11 CN disclosed
CN-103348972-A Controlled release granules SYNGENTA PARTICIPATIONS AG 2013-10-16 CN disclosed
CN-101173180-B Phosphor and tungsten hetero-multi-quaternary ammonium salt desulfurizing agent and preparation method thereof UNIV HARBIN ENG 2011-08-03 CN disclosed
CN-101505597-A Controlled release granules SYNGENTA PARTICIPATIONS AG (CH) 2009-08-12 CN disclosed
CN-101173180-A Phosphor and tungsten hetero-multi-quaternary ammonium salt desulfurizing agent and preparation method thereof UNIV HARBIN ENG (CN) 2008-05-07 CN disclosed
EP-0535980-B1 2-Pyridone derivatives, a process for their preparation and their use as fungicides SUMITOMO CHEMICAL CO (JP) 1995-12-20 EP disclosed
US-5169431-A Herbicides SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1992-12-08 US disclosed
EP-0476697-A1 Benzofuranyl- and benzothiophenyl substituted uracil derivatives, and their production and use as herbicides SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1992-03-25 EP disclosed
US-4853380-A REACTING SULFONATED HETEROCYCLIC SULFUR COMPOUNDS WITH DIAMINES OF PLATINUM NITRATE INTERNATIONAL PHARMACEUTICAL PRODUCTS (US) 1989-08-01 US disclosed